A Study to Evaluate How VI-0521 Affect Cardiac Repolarization in Healthy Male and Female Volunteers
NCT00839891
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
112
Enrollment
INDUSTRY
Sponsor class
Conditions
Torsades de Pointes
Interventions
DRUG:
VI-0521
Sponsor
VIVUS LLC